Email:
Tel: 
Cancer is a series of diseases involving abnormal cell growth with the potential to invade or spread to other parts of the body. In 2015, there were about 90.5 million people develop cancer. Up to 2019, there are 18 million new cancer cases every year. It caused about 8.8 million deaths with a 15.7% fatality rate. The most common types of cancer in females are breast cancer, colorectal cancer, lung cancer, and cervical cancer. The most common types of cancer in males are lung cancer, prostate cancer, colorectal cancer, and stomach cancer. Treatments for cancer are the trickiest, and the hottest, and thus the study on targets against cancer is an enduring area. CD BioSciences offers customized services on developing cancer models, including breast, pancreatic, liver, prostate, lung, stomach, renal, leukemia head & neck, bladder, ovarian, lymph, and colorectal cancers.
Breast cancer was the most diagnosed cancer and the leading cause of cancer-related death among females worldwide in 2018. Metastatic disease accounts for more than 90% of breast cancer-related deaths.
CD BioSciences offers various models for breast cancer, including two-dimensional (2D) cell line models, human tumor xenotransplantation model, organoid models, organ tissue section model and others. We have rich experience and professional technicians to develop the specific breast cancer models for your targeted drug discovery project according to your requirement.
Pancreatic cancer is one of the deadliest cancers in the world and the overall five-year survival rate was only 9.3% in pancreatic cancer patients. There are more than 400,000 people dead of pancreatic cancer annually in the world. Existing drug treatments against pancreatic cancer are very limited. It is benefit to discovery drugs against pancreatic cancer that establishing ideal pancreatic cancer models to simulating the pathological processes in patients, including human pancreatic cancer cells malignant transformation, invasion, invasion and distant metastasis and others.
CD BioSciences has rich experience in establishing pancreatic cancer models. We have various specific pancreatic cancer cell lines and various model animals to provide common pancreatic cancer models or establish pancreatic cancer models according to your requirements.
Common Pancreatic Cancer Models
Pancreatic cancer cell line model, pancreatic cancer PDX model, pancreatic cancer organoid cell model, etc.
Pancreatic Cancer Cell line
Paca-2, SW1990, Patu8988, Bxpc-3, Capan-1/2, Aspc-1, jr305, PC-3, etc.
Primary liver cancer is one of the most common malignant tumors in cancer, liver cancer affects 16 out of every 100,000 people worldwide. However, the ways of radiotherapy and chemotherapy against liver cancer are very limited. Chemotherapy can relieve the disease to some extent, but drug resistance occurs in a very short time, and subsequently, the effect will decrease immediately. Based on these limitations, more and more researchers are attracted to cancer-targeted drugs discovery, which always inhibits cancer significantly and have little effect on normal cells.
CD BioSciences offers various liver cancer models, including spontaneous hepatocellular carcinoma models, induced hepatocellular carcinoma models, transplanted hepatocellular carcinoma models, transgenic hepatocellular carcinoma model. Besides, we provide customized services on liver cancer models according to your experimental requirement.
Prostate cancer is cancer of the prostate, which is a gland in the male reproductive system that surrounds the urethra just below the bladder. Prostate cancer is the second-most common cancer in the world, meantime, it is the fifth-leading cause of cancer-related death in men. There are 1.1 million men diagnosed with prostate cancer worldwide every year and 307,000 patients dead of it. The most common treatments against prostate cancer are still surgery, radiation therapy, chemotherapy, hormonal therapy, external beam radiation therapy, and particle therapy and high-intensity focused ultrasound, while these treatments can be difficult.
An ideal prostate cancer model helps to investigate the activity and mechanism of drugs against prostate cancer, which accelerate your targeted drug discovery project.
CD BioSciences offers prostate cancer patient-derived tumor xenograft (PDX) models, prostate cancer orthotopic transplantation tumor models, prostate cancer patient-derived organoid (PDO) models and others. In addition, we provide customized services on prostate cancer models according to your experimental requirements.
Cancer has always been a great threat to human health. Researchers have never stopped looking for ways to overcome cancer. Even rare cancers, they also can cause tens of thousands of deaths every year. Cancer model is key method to evaluate the treatment effect. CD BioSciences runs various cancer models for many types of cancer, including but not limited to cell derived xenograft models, patient-derived xenografts models, patient-derived organoid models, orthotopic transplantation tumor models and others. In addition, we offer customized services on establishing cancer models to help your targeted drugs discovery project.
Available Model Animals
Rodents, zebrafish, rabbits, dogs, cats, pigs, tree shrews, monkey, non-human primates (NHPs) Non-mammals.
Advantages of CD BioSciences
Extensive Experience, Professional Technicians, Advanced Equipment, Customized Services.
